MedTrace Logo

Hemostatic Powder Versus Clinical Management for the Treatment of Upper Gastrointestinal Bleeding From Tumor Lesions

NCT02820077 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 62

Last updated 2020-08-31

No results posted yet for this study

Summary

This study evaluates the efficacy of the endoscopic hemostatic powder for the treatment of bleeding from malignant lesions of the upper GI tract. Half of participants will receive hemostatic powder and half will be submitted to standard treatment.

Conditions

  • Gastrointestinal Hemorrhage
  • Gastrointestinal Neoplasms

Interventions

DEVICE

Hemospray (Endoscopic treatment with hemostatic powder)

Malignant bleeding lesions will be treated with endoscopic powder and patients will receive optical clinical management afterwards

Sponsors & Collaborators

  • Instituto do Cancer do Estado de São Paulo

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-06
Primary Completion
2020-01-24
Completion
2020-08-27

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02820077 on ClinicalTrials.gov